Support Healthy and Fulfilling Lives

Initiatives in Supporting Healthy and Fulfilling Lives

In the current era of 100-year life, it is everyone’s wish to live a long, healthy life. An aging population and the availability of advanced medical care, on the other hand, have been pushing up the financial burden on individuals, their families and society every year. As an insurance company covering disease and illness through life and non-life insurance products, Tokio Marine Group aims to leverage its extensive expertise to offer high-value-added products and services. With these initiatives, the Group will contribute to solving social issues, such as extending healthy life and asset lives, as well as support a healthy and enriching lifestyle.

Related SDG Goals

  • 1. No poverty
  • 2. Zero hunger
  • 3. Good health and well-being
  • 10. Reduced inequalities
  • 12. Responsible consumption and production
  • 16. Peace, justice and strong institutions

Progress of Material Issues

About2,200companies
Health and productivity management support provided to:
(FY2023)
Health & Productivity Stock : Selected8times
Health & Productivity Management Outstanding Organization : Recognized8times

Case Studies

Promoting Health and Cancer Insurance That Supports Healthy Living

In anticipation of an era of the 100-year life, Tokio Marine & Nichido Life has been sincerely addressing customer issues and societal challenges, including the growing elderly population, the advancement of medical technologies (presymptomatic/preventive healthcare) and asset building for a long retirement period. The company also utilizes cutting-edge technologies to provide original, innovative products and services.

In August 2023, Tokio Marine & Nichido Life launched the industry’s first medical insurance product and service supporting healthy living, which covers eight lifestyle-related diseases. The coverage starts from outpatient treatment regardless of whether hospitalization is required.

Advances in medical technology have greatly transformed the cancer treatment landscape. Some of the latest treatments, such as anticancer drugs, entail a considerable time lag until Japanese public health insurance applies, even though they are already in use overseas, which results in high treatment expenses and discourages some patients from receiving their preferred treatment. For new treatment techniques like this, the company has developed and offers a new rider for specific cancer treatments that provides coverage of up to 100 million yen, delivering a new form of security to cancer treatment.

News & Insights